Clovis Oncology, Inc.
CLVSQ | $0.015 -3.33% 890K
|
n/a
(0.0% 1d) (0.0% 1m) (-26.4% 1y) (0.0% 2d) (-18.9% 3d) (0.0% 7d) (-63.82% volume)
Earnings Calendar: 2023-02-22
Market Cap: $ 2,182,306
https://www.clovisoncology.com
Sec Filling | Patents | 429 employees
(US) Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.
cancer diagnostics
add to watch list Paper trade email alert is off
Press-releases
Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period (2019-2032), Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo
Published: 2023-10-04 (Crawled : 21:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
RVMD S | $35.81 -2.74% -2.82% 1M
|
Health Technology
|
| O: -0.58%
H: 4.83%
C: 4.38%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 0.24%
H: 3.66%
C: 1.95%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -0.44%
H: 1.52%
C: 0.08%
AXSM | $65.81 -5.6% -5.93% 830K
|
Health Technology
|
| O: -0.43%
H: 4.97%
C: 4.71%
lung companies cancer study market
Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period (2023-2032), Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis
Published: 2023-09-06 (Crawled : 21:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.76%
H: 2.15%
C: 1.6%
RCUS 4 | $14.84 0.0% 840K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: -4.96%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -1.5%
H: 0.83%
C: -1.69%
IMMP | News | $2.205 -2.43% -2.73% 270K
|
Health Technology
|
| O: 0.53%
H: 0.53%
C: 0.53%
GTHX | $4.16 -2.8% -2.88% 690K
|
Health Technology
|
| O: -0.6%
H: 1.2%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -1.16%
H: 1.14%
C: 0.89%
companies breast cancer novartis market
Leiomyosarcoma Pipeline Research Report 2023: Comprehensive Insights About 10+ Companies and 10+ Pipeline Drugs - Assessment by Product Type, Stage, RoA, and Molecule Type
Published: 2023-07-15 (Crawled : 04:20) - prnewswire.com
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
| Email alert
Add to watchlist
CLVSQ | $0.015 -3.33% 890K
|
n/a
| Email alert
Add to watchlist
companies report pipeline research
ADC Therapeutics Announces Evolution of Board of Directors
Published: 2023-06-15 (Crawled : 11:00) - globenewswire.com
CLVSQ | $0.015 -3.33% 890K
|
n/a
|
| O: 2.34%
H: 22.14%
C: 4.2%
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
|
| O: -0.87%
H: 3.96%
C: 1.76%
therapeutics
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -0.74%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -0.25%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.08%
H: 0.21%
C: -0.1%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.01%
H: 0.08%
C: -0.95%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.16%
C: -0.47%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.04%
H: 0.21%
C: -0.25%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.08%
H: 0.66%
C: 0.61%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: -0.32%
H: 2.91%
C: 2.75%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: 0.01%
global disease report therapeutics cancer market
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10